Cargando…
Spontaneous bacterial peritonitis in hepatocellular carcinoma after PD-1 inhibitor therapy: two clinical cases
With the recent advances in immunotherapy, especially programmed cell death protein 1 (PD-1) inhibitors, the treatment of hepatocellular carcinoma (HCC) patients has entered a new stage. However, few reports have focused on spontaneous bacterial peritonitis (SBP) after PD-1 inhibitor treatment of in...
Autores principales: | Liu, Jianwei, Xue, Hui, Bai, Shilei, Wang, Jie, Zhang, Yue, Liu, Liu, Zhang, Lei, Yang, Zhao, KuiWang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649979/ https://www.ncbi.nlm.nih.gov/pubmed/36387537 http://dx.doi.org/10.1016/j.heliyon.2022.e11248 |
Ejemplares similares
-
PD-L1 combined with HDAC9 is a useful prognostic predictor in hepatocellular carcinoma
por: Yang, Zhao, et al.
Publicado: (2021) -
Prognosis of Spontaneous Bacterial Peritonitis in Hepatocellular Carcinoma Patients
por: Kim, Jeong Han, et al.
Publicado: (2018) -
Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE
por: Bai, Shilei, et al.
Publicado: (2023) -
Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis
por: Miozzo, Suelen A S, et al.
Publicado: (2017) -
Listerial Spontaneous Bacterial Peritonitis
por: Samant, Samira, et al.
Publicado: (2022)